AzTrials
AzTrials

EchocardiographyEchoPACNCT03133962

Evaluation of the Contribution of the Ultrasound Tracking and the Positioning of the Distal End During the Implantation of Implantable Chamber or Long-lasting Venous Catheter

A study testing Adult patients who are candidates for a CAP or long-term central catheter placement in people with Echocardiography and Implantable Chamber, run by Centre Hospitalier Universitaire, Amiens at 1 site in France.

Withdrawn

Withdrawn. The study stopped before anyone enrolled.

Official record
Search all trials

Trial summary

Given the increase in the number of PAC implants or long-term catheters, and the ease of access to cardiac ultrasound in the operating theaters, the investigator thought to use ultrasound to PAC or long-term catheters. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Echocardiography, Implantable Chamber
What is being tested?
Adult patients who are candidates for a CAP or long-term central catheter placement
Could I receive a placebo?
No, everyone receives an active treatment
How many people
0 participants
Where
1 siteFrance
Study dates
3 Nov 2014to 21 Apr 2017
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • All adult patients are candidates for a long-term CAP or central catheter placement.
  • Benefiting from sedation or general anesthesia.

Who cannot join

  • Patient aged <18 years.
  • Pregnant woman.
  • Lack of anesthesiologist with knowledge of ultrasound.
  • Site of femoral puncture

Trial locations and contacts

1 site in 1 country.

France1 site
  • CHU Amiens Picardie

    Amiens, Picardie, 80054

Other trials in France

About this study

Given the increase in the number of PAC implants or long-term catheters, and the ease of access to cardiac ultrasound in the operating theaters, the investigator thought to use ultrasound to PAC or long-term catheters.

The investigator considers cardiac echocardiography through its costal pathway to locate the correct positioning of the distal end of the catheter in a manner equivalent to the scopic locating with all the side effects of the irradiation and with Equivalent efficiency

Being tested
Adult patients who are candidates for a CAP or long-term central catheter placement

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Adult patients who are candidates for a CAP or long-term central catheter placementOther

    Evaluate the feasibility of finding the correct positioning of the distal end of the PAC or of the long-term catheter by cardiac ultrasound in comparison with the brightness scopy, reference method.

Study groups in NCT03133962
Study groupRoleWhat they receive
Patients applying for CAP or long-term central catheterOtherNot described
Receives: Other: Adult patients who are candidates for a CAP or long-term central catheter placement

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Good positioning of the distal end of the catheter by ETT, without repositioning following the scopy

    Measured: 1 day

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted28 Apr 2017
  2. Study start3 Nov 2014
  3. Primary completion21 Apr 2017
  4. Study completion21 Apr 2017

Why it stopped: Decision of the investigator

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
0 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03133962
Sponsor's protocol ID
PI2014_843_0013
Acronym
EchoPAC
Status last verified
May 2017
First submitted
25 Apr 2017
Last updated
12 May 2017
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Adult patients who are candidates for a CAP or long-term central catheter placement in people with Echocardiography and Implantable Chamber, run by Centre Hospitalier Universitaire, Amiens at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: withdrawn, as of the sponsor's last update on 12 May 2017. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study was withdrawn before enrolling participants, so there are no results.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Good positioning of the distal end of the catheter by ETT, without repositioning following the scopy (time frame: 1 day). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 12 May 2017.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in